Induction of T cell responses to an antigenic peptide that is known to bind a major histocompatibility complex molecule is a function of either the T cell receptor (TCI<) repertoire or regulatory influences by CD8 or CD4 regulatory T cells. We have tested the hypothesis that a lack of 10 TC1L V~ gene segments in Vf3 a mice may result in an incomplete repertoire of regulatory T cells involved in maintaining peripheral tolerance. Such a hole in the repertoire of regulatory cells could result in expression of T cell responses to antigenic determinants that normally remain undetected in mice with a wild-type repertoire of TCR V~ gene segments. We show here that H-2 a mice respond to the peptide 74-96 of hen egg-white lysozyme (HEL) when they are ofV~ a haplotype at their TCR locus. The wild-type (g~ b) H-2 a mice with their complete set of 20 TC1L V~3 gene segments fail to respond to HEL 74-96. The 74-96-specific T cell responsiveness was revealed in the wild-type (V~3 b) mice when they were treated in vivo with anti-CD8 antibody, implicating the existence ofregnlatory cells that prevent expression of T cell responses specific for peptide 74-96. This is a demonstration that holes in the regulatory T cell repertoire can, in certain circumstances, become beneficial to the host, for example, in susceptibility against pathogens.
D
ue to the loss of 10 T cell receptor V~3 gene segments from their germline repertoire, V~ a mice possess a truncated TCP. repertoire (1, 2) . We have previously shown that mice with such a deletion in their TCP. Vr genes (V~ truncated haplotype, Vf3 ~) are unable to respond to two antigenic determinants (sperm whale myoglobin [SWMp 110-121/E~,aAr a and myelin basic protein [MBP] 1-11/A ~ (2). These experiments indicated that there is an absolute limit to the flexibility inherent in the TCR repertoire: the absence of specific TCR V~ gene segments resulted in holes in T cell responsiveness to the above-mentioned determinants (2, 3) .
One mechanism for maintenance of peripheral tolerance to self-and foreign antigens involves regulatory cells that inhibit the function of antigen-specific T cells such that there is no response upon immunization with specific peptide or protein antigens despite the existence of T cells that can recognize their determinants. Peripheral tolerance to self-peptides exists to prevent autoreactivity by T cells that have escaped deletion during thymic selection (4) (5) (6) . Peripheral tolerance to foreign antigens is likely to exist to prevent immune pathology caused by the persistence of ~Abbreviations used in this paper: HEL, hen egg-white lysozome; MBP, myelin basic protein; Pal, recombinant inbred; SWM, sperm whale myoglobin. certain activated T cells, for example in several parasitic systems (7) . Peripheral tolerance or suppression to foreign antigens could also exist as a fortuitous consequence of the cross-reactivity of self-directed regulatory cells. Thus, (a) many foreign antigen determinants associated with self-MHC molecules are structural mimics of MHC-restricted self-determinants and thus should be susceptible to the same regulation as self-antigens (8) , and (b) certain foreign and self-determinants induce T cells bearing similar or identical TCR V region gene segments (3, 9) . TCtl_-centered regulatory cells that recognize specific TCR determinants may therefore be able to regulate both foreign and self-antigens through TCR-targeted circuitry (for reviews see references 9 and 10).
We hypothesized that regulatory cells controlling the expression of immune responsiveness toward certain antigenic determinants might also have a limited T cell repertoire. Thus, a lack of 10 TCP, Vf3 gene segments in V~3" mice could possibly give rise to holes in the repertoire of the regulatory cells, analogous to the holes in the repertoire ofSWM 110-121/E~dA~ d-and MBP 1-11/Au-specific CD4 T cells that we had previously reported. The outcome of such a hole in the repertoire of regulatory cells would be the expression of T cell responsiveness to normally nonimmunogenic determinants.
We show in this report that a strong T cell response, specific for peptide 74-96 of hen egg-white lysozyme (HEL), can be induced in H-2 d mice only when they lack 10 TCR gene segments, presumably encoding a TCR [3 chain on a potent regulatory T cell. None of the three strains of H-2 a mice (BALB/c, B10.D2, and FI[BALB/c • SJL]) with an intact repertoire of 20 TCR V~ gene segments responds to the peptide HEL 74-96. However, two different H-2 d recombinant inbred mouse strains ([CxJ]9, [CxJ]8) with the V~ :~, truncated set of TCR V~ gene segments show very strong T cell responses to this peptide. Furthermore, although 74-96-specific long-term CD4 + T cell lines and clones can be readily derived from V~ a mice, it was not possible to obtain such a long-term T cell line from BALB/c (V~ t') mice (data not shown). We also show that in vivo treatment with anti-CD8 antibodies of nonresponsive, wild-type V~ 6 mice, allows expression of T cell responsiveness to HEL 74-96. These results reveal a hole in the regulatory repertoire of CD8 T cells in V~ a mice that usually controls the response to HEL 74-96.
Materials amd Methods
Mice. Mice either were bred at our own laboratory or were obtained from The Jackson Laboratory (Bar Harbor, ME). Specificity Assays. For antigen-primed LNC, LNC proliferation assays were performed as described earlier (2) . Briefly, 4 • 10 s (unless otherwise indicated) LNC from individual mice were cultured with 14, 7, or 3.5 I.tM concentrations ofpeptide 74-96 or HEL in 0.2 ml/well of HL-1 medium (Ventrex Laboratories Inc., Portland, ME), supplemented with 2 mM glutamine, 100 U/nil of penicillin, and 100 I, tg of streptomycin. All cultures were done in triplicate. Proliferation was measured by addition of 1 I~Ci of [3H]thynfidine for the last 18 h ofa 5-d culture, and the incorporation was assayed by scintillation counting.
Antigens and
T CellHybrids. 10 s T hybridoma cells were cultured with various concentrations of the peptide 74-96, or the pepscan peptides within the sequence 70-104, or HEL, with 5 • 10 s irradiated BALB/c spleen cells as APC in 0.2 ml of DMEM (Flow Laboratories, Irvine Ayrshire, Scotland) supplemented with 2 nlM glutamine, 0.05 mM 2-ME, 100 U/ml penicillin, 100 ~g/ml streptomycin and 10% heat-inactivated fetal calf serum (Hyclone, Logan, UT), as described (2, 11) . All cultures were performed in triplicate. The supernatants collected 24 h later were assayed /'or IL-2 activity on the IL-2/IL-4-dependent cell line, HT-2. 1{) 4 HT-2 cells were cultured with medium alone or supernatants for 48 h. Proliferation was measured by adding 1 btCi [3H]thymidine during the last 18 h of culture and incorporation assayed by liquid scintillation counting.
Results
We compared T cell responsiveness in HEL-inmmnized H-2 'i mice with and without a wild-type repertoire, to test the hypothesis that the lack of 10 TCR VI3 gene seglnents in V[3 ~ mice could result in a hole in the repertoire of regulatory T cells and lead to a manifestation of T cell responsiveness to certain determinants that are normally nonimmunogenic. For these initial experiments, we used the wild-type (v~b), H-2 a haplotype BALB/c mice and the RI, H-2 ~ haplotype mice, (CxJ)8 and (CxJ)9, that have a truncated (V~9 repertoire at their TCR locus. The (CxJ)9 and (CxJ)8 mice have been described earlier (2) . A pepscan analysis (using a series of overlapping peptides that walk the whole antigen [HELl in single anfino acid steps) of LNC from HEL-primed (CxJ)9 (H-2 d, V~3 ') and BALB/c (H-2 d, V~ b) mice revealed that only V~ a mice were able to respond to peptides in the 74-96 region of HEL (data not shown). We therefore selected peptide 74-96 (a tryptic peptide of HEL), to further study the differential responsiveness ofV~3 ~' and V~ b mice in this haplotype.
In the H-2 d Haplotype, Peptide HEL 74-96 Induces T Cell
Responses Exclusively in Vls" Mice. Fig. 1 a, top left) . The mean delta counts per minute (cpm of LNC incubated with the peptide 74-96 minus the cpm of cells incubated medium alone) of 21 V~ a mice tested individually is 128,000 and that of 16 V~ b mice is 5,850. With HEL (Fig. 1 a, bottom left) (Fig. 1 b) . The responsiveness of (CxJ)8 and (CxJ)9 mice might have been owing to contribution of portions of the SJL genome found in each of these strains, other than within the V~ ~ region. However, this is unlikely because of the lack of 74-96-specific T cell responses found in primed FI(BALB/c X SJL) mice ( Fig. 1 a, left) . Fig. 3 shows the stimulation of four representative 74-96-specific T cell hybridomas derived from (CxJ)9 mice using pepscan analysis within the sequence 70-104. The minimal cores recognized by these T hybrids are (clockwise from top left): 77-90, 72-85, 71-84, and 72-84, respectively. It is surprising that 72-85, 71-84, and 72-84 are minimal cores for the T hybrids derived from mice immunized with peptide 74-96, which lacks residues 71 to 73. This result, however, is reminiscent of and is consistent with our recent report that a single TCR can be stimulated by multiple peptide cores (12) . Thus, it is likely that 72-85, 71-84, and 72-84 each contain one of the peptide cores recognized by the latter three T hybrids, respectively.
BALB/c (H-2 a) Mice Are Able to Process and Present Peptide 74-96 to T Cell Hybrids Derived from (CxJ)9 Mice and Specific for Various Determinants within the Peptide 74-96.
As BALB/c splenic cells were used as APC in these experiments, it is evident that BALB/c APC are able to process and present each of these determinants to 74-96-specific T cells. Furthermore, each of these T cell hybridomas can be activated by HEL (data not shown), indicating the ability of BALB/c mice to generate all the determinants within peptide 74-96, from the intact protein or from the peptide. We would like to point out that even though it was possible to isolate 74-96-specific CD4 T cell hybrids from V~ b BALB/c mice, their cloning efficiency was more than 10,000 times lower than that of the cloning efficiency of 74-96-specific T cell hybrids from (CxJ)9 mice under equivalent conditions (Nanda, N.K., unpublished data). Cloned T hybrids derived from BALB/c mice nevertheless showed a similar diversity of recognition of different minireal determinants on the peptide 74-96.
In Vivo Deletion of CD8 T Cells Reveals the Expression q[ Responsiveness to Peptide 74-96 in VJ'
Mice. To explore the possibility that a TCR V~ gene required by a regulatory population and missing in V~ ;~ mice was the cause of the responsiveness of (CxJ)9 mice to 74-96, we sought proof for The data are expressed as described in Fig. 1 . In vivo depletion ofCD8 T cells in (CxJ)9 mice resulted in a slight decrease (10-29%) in 74-96~pe-cific responses of their LNC (data not shown). The decrease in proliferative responses in (CxJ)9 mice could possibly be due to bystander stimulation of CD8 T cells and its effects on proliferative T cell responses.
the existence of this regulatory CD8 population in wildtype V~ b mice. BALB/c (V~ b) mice were treated in vivo with anti-CD8 antibody 4 d before immunization with peptide 74-96. Mice treated with anti-CD8 antibody showed a marked depletion ofCD8 + T cells: on day 4 after anti-CD8 treatment (at the time mice were immunized with the peptide), treated mice had <1% CD8 T cells. By day 13 after the treatment with anti-CD8 antibody (9 d after immunization), anti-CD8-treated mice had regained 2.8-4% of their CD8 + T cells, whereas mice treated with isotype control antibody rlgG2a had 13-15% CD8 + T cells (data not shown) in their LNC. It is evident from Fig. 4 that each of the seven anti-CD8 antibody-treated BALB/c mice showed a considerable responsiveness to peptide 74-96, whereas those treated with PBS or an isotype control antibody remained unresponsive to this determinant. The mean delta counts per minute of three BALB/c mice treated with PBS is 5,040, that of three BALB/c mice treated with control antibody (rIgG2b) is 6,270, and that of seven BALB/c mice treated with anti-CD8 antibody is 63,140. Anti-CD8-treated, peptide 74-96-immunized BALB/c (V~ b) mice showed generally lower in vitro recall responses to the whole protein HEL than V~ ~ mice (see Fig. 1 a) .
Discussion
It is evident that constraints in T cell recognition would create gaps not only in the direct repertoire of responsive cells but also in the repertoire of regulatory cells (2, 3) . Thus, the absence of 10 TCR V~ gene segments in V~ a mice resulted in a hole in the repertoire of CD4 T cell immune responses to two antigenic determinants, SWM 110-121/E~dA~ d and MBP 1-11/A u (2). We now show that V~ a mice with a truncated repertoire of TC1K V~ gene segments also have a hole in the repertoire of their regulatory CD8 T ceils that results in disclosing an underlying T cell imnmne responsiveness to HEL 74-96/A d. The response to this determinant is absent in the wild-type mice displaying a complete repertoire of TClK Vf~ gene segments. CD8 T cell ablation in these wild-type mice, however, results in expression of 74-96--specific T cell responses. Thus, lack of responsiveness in the V~ b mice cannot be attributed to the absence of a 74-96--specific CD4 T cell repertoire or to a defect in antigen processing.
This report is a first demonstration of expression of a CD4 T cell response to a peptide determinant in wild-type mice by simple in vivo ablation of CD8 T cells. CD8 T cells have been implicated in downregulation of immune responses in several systems over the last two decades (for reviews see references 13 and 14) . Most of these studies involved complicated in vitro cell reconstitution experiments (13, 14) or adoptive transfer systems (15) . Moreover, these studies focussed on experimental inhibition of either T or B cell function, which is distinct from our system in which the Vf~ b, H-2 d mice do not respond upon immunization with peptide 74-96 of HEL with CFA, a traditionally powerful immunization regimen. In addition, the expression of CD4 T cell responses in V~ ~ mice, without having to deplete T cells, involved no experimental manipulation. Our results are aligned with more recent observations where the direct approach of in vivo CD8 T cell depletion was used in the murine experimental autoimmune encephalomyelitis (EAE) model (B10.PL, H-2 u mice), and shown to result in inducing chronicity of disease as well as a lack of resistance to a second induction of disease in these mice (16) . Similar results were obtained using mutant (CD8 -/-) mice that lack the CD8 gene and therefore CD8 T cells. CD8 /-mice undergo more relapses of EAE than wild-type mice immunized by MBP (17) . These experiments showed that CD8 T cells, under normal circumstances, downregulate the function of autoimmune CD4 T cells and thus prevent relapses or reinduction of EAE.
Why do V~fl, H-2 a mice respond to immunization with peptide HEL 74-96 without having been depleted of CD8 T cells? As discussed above, one reason could be the contribution of some genes (other than the TCR genes) from the SJL parent of the RI(CxJ)9 and (CxJ)8 mice (as these mice were derived from BALB/c and SJL grandparents). This appears unlikely as (BALB/c • SJL)FI, H-2 axs mice (expressing all genes contributed by the SJL parent) are unable to respond to peptide 74-96. Another reason could be that the (CxJ)9 and (CxJ)8 mice express quantitatively smaller amounts of a self-superantigen-like gene product which, when expressed in larger amounts in BALB/c mice, results in the deletion of HEL 74-96-specific CD4 T ceils. The absence of 74-96-specific T cell deletion in (CxJ)9 and (CxJ)8 mice could conceivably enable them to respond to HEL 74-96. This is very unlikely because BALB/c mice are able to respond to HEL 74-96 after having been depleted of CD8 T cells. Our results favor the explanation that the lack ofT cell responses to HEL 74-96 in wild-type V~ b mice and their expression in Vffl mice is solely determined by the TCR V~ locus: it is the lack of 10 TCR V~ gene segments underlying the existence of a regulatory contingent, that leads to responsiveness in V~3 a mice without having to deplete them of CD8 T cells. These CD8 T cells able to downregulate 74-96-specific T cell responses are present in the wild-type mice and are missing in (CxJ)9 and (CxJ)8 mice because of the absence of a critical TCtL V~3 gene segment in these mice. It is likely that further examples of neo-responses to determinants on other antigens will be detected in such mice.
Our results present evidence that deletion of multiple TCR. V~3 gene segments in an individual can not only result in a lack ofimmunogenicity, as shown earlier, but also in a gain of immunogenicity to an antigenic determinant, as shown in the current report (also discussed in 2). During evolution, a balance between these opposite repercussions from a loss ofTCR VI3 gene segments may have resulted in expression of different numbers of deletion ligands (selfsuperantigens) in different strains of mice, leading to a spectrum of possibilities of loss of TCR V~ segments across the species (18, 19) , which in turn results in gain or loss ofimmunogenicity to different antigenic determinants in different strains. In addition, these results provide direct evidence that peripheral tolerance to specific antigenic determinants can be mediated by CD8 T cells and can be overcome by in vivo depletion ofCD8 T cells.
What is the mechanism by which CD8 T cells prevent the expression of HEL 74-96-specific CD4 T cell responses in wild-type mice? The answer is unclear. We have now succeeded in isolating cloned CD8 T cell hybridomas specific for HEL 74-96 from wild-type BALB/c mice (Nanda, K. et al., unpublished observations). Our preliminary results have revealed that these CD8 T ceils are unique in possessing a distinct set of requirements for activation as compared with conventional, cytotoxic CD8 T cells. For example, irradiated splenic APC are unable to activate these CD8 T cells. Whether or not, and how these cells downregulate HEL 74-96~pecific CD4 T cells, remain to be learned.
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